These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30089595)

  • 101. Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.
    Fan X; Liu B; Xu H; Yu B; Shi S; Zhang J; Wang X; Wang J; Lu Z; Ma H; Zhou X
    Hum Pathol; 2013 Aug; 44(8):1499-507. PubMed ID: 23465272
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases.
    Inoue T; Matsumura Y; Araki O; Karube Y; Maeda S; Kobayashi S; Chida M
    Ann Thorac Cardiovasc Surg; 2018 Feb; 24(1):1-5. PubMed ID: 29093430
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
    Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Diagnostic value of solid component for lung adenocarcinoma shown as ground-glass nodule on computed tomography].
    Ge X; Gao F; Li M; Chen Y; Lü F; Ren Q; Hua Y
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):1010-3. PubMed ID: 24851690
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.
    Miao Y; Zhang J; Zou J; Zhu Q; Lv T; Song Y
    Transl Lung Cancer Res; 2017 Feb; 6(1):14-22. PubMed ID: 28331820
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
    Li F; Sone S; Abe H; Macmahon H; Doi K
    Radiology; 2004 Dec; 233(3):793-8. PubMed ID: 15498895
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.
    Goto E; Taki T; Nomura K; Miyakami Y; Miyoshi T; Tane K; Samejima J; Aokage K; Nagamine M; Sakashita S; Sakamoto N; Kojima M; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2024 Jun; 192():107830. PubMed ID: 38805901
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma.
    Okamoto T; Kitahara H; Shimamatsu S; Katsura M; Takada K; Fujishita T; Suzuki Y; Morodomi Y; Tagawa T; Maehara Y
    Anticancer Res; 2016 Jun; 36(6):3057-63. PubMed ID: 27272827
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Ten-Year Follow-up Results of Pure Ground-Glass Opacity-Featured Lung Adenocarcinomas After Surgery.
    Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
    Ann Thorac Surg; 2023 Aug; 116(2):230-237. PubMed ID: 36646243
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 113. MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
    Kwon D; Koh J; Kim S; Go H; Kim YA; Keam B; Kim TM; Kim DW; Jeon YK; Chung DH
    Lung Cancer; 2017 Apr; 106():131-137. PubMed ID: 28285687
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Advanced lung adenocarcinoma harboring a mutation of the epidermal growth factor receptor: CT findings after tyrosine kinase inhibitor therapy.
    Choi CM; Kim MY; Lee JC; Kim HJ
    Radiology; 2014 Feb; 270(2):574-82. PubMed ID: 24086072
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors.
    Mimae T; Tsutani Y; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
    Ann Thorac Surg; 2020 May; 109(5):1530-1536. PubMed ID: 31981497
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
    Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
    Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Three-Dimensional Ground Glass Opacity Ratio in CT Images Can Predict Tumor Invasiveness of Stage IA Lung Cancer.
    Yu WS; Hong SR; Lee JG; Lee JS; Jung HS; Kim DJ; Chung KY; Lee CY
    Yonsei Med J; 2016 Sep; 57(5):1131-8. PubMed ID: 27401643
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung.
    Luo YH; Wu CH; Huang CY; Wu CW; Wu WS; Lee YC; Whang-Peng J; Chen YM
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e440-e448. PubMed ID: 27550395
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.
    Matsumura M; Okudela K; Nakashima Y; Mitsui H; Denda-Nagai K; Suzuki T; Arai H; Umeda S; Tateishi Y; Koike C; Kataoka T; Irimura T; Ohashi K
    PLoS One; 2019; 14(4):e0215237. PubMed ID: 30973916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.